<DOC>
	<DOC>NCT00102791</DOC>
	<brief_summary>The purpose of this study is to compare the effects of ICA-17043 to placebo with or without hydroxyurea (an oral drug used for treatment of sickle cell disease) in patients with sickle cell disease who have had 2 or more acute sickle-related painful crises requiring a visit to a medical facility within the past 12 months.</brief_summary>
	<brief_title>A Stratified Sickle Event Randomized Trial (ASSERT)</brief_title>
	<detailed_description />
	<mesh_term>Anemia, Sickle Cell</mesh_term>
	<criteria>16 to 65 years of age (inclusive) Male or female (not capable of becoming pregnant or using appropriate birth control) Medical history of sickle cell disease Have a history of at least two or more acute sicklerelated painful crises requiring a visit to a medical facility within the preceding 12 months Hemoglobin &lt;4 or &gt;11 g/dL On a chronic transfusion program Has significant active and poorly controlled (unstable) cardiovascular, neurologic, endocrine, hepatic, or renal disorders clearly unrelated to sickle cell disease</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Sickle Cell Anemia</keyword>
</DOC>